iSpecimen Inc. Marketable Securities (Current)
iSpecimen Inc. (ISPC) had Marketable Securities (Current) of $6.21 million as of 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:MarketableSecuritiesCurrent · last filed 2023-08-02
- 2023-06-30: Marketable Securities, Current $6.21M.
- 2023-03-31: Marketable Securities, Current $7.26M.
| Period end | Marketable Securities, Current |
|---|---|
| 2023-06-30 | $6.21M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $7.26M 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |